Enlivex Therapeutics

/Enlivex Therapeutics

Overnight

Enlivex Therapeutics

Biotechnology

Overnight offering: We are a clinical stage macrophage reprogramming immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing.

Symbol

ENLV

Last Closing Price
$24.00

Shares
500,000

Anticipated Date
February 10, 2021

Underwriters
H.C. WAINWRIGHT & CO., INC.

This offering is no longer available

To view the prospectus for Enlivex Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange